FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ AUSTEDO XR extended-release tablets as a once-daily treatment option for adults with tardive dyskinesia (TD) and Huntington’s disease (HD) chorea. The approval has been granted …